Company Profile

Adeza Biomedical Corporation (AKA: Cytyc Corporation)
Profile last edited on: 2/18/2019      CAGE: 1YYV0      UEI: USTTJK98F2V8

Business Identifier: Women's health care and cancer diagnostics
Year Founded
First Award
Latest Award
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1240 Elko Drive
Sunnyvale, CA 94089
   (408) 745-0975
Location: Single
Congr. District: 17
County: Santa Clara

Public Profile

Acquired in 2007 by Cytyc Corporation, a leading global women's health company, .Adeza Biomedical is focused to diagnostic products and services targeted to women's health care - primarily the diagnosis of pregnancy-related and female reproductive disorders, including preterm birth, preeclampsia, endometriosis and infertility. Adeza manufactures, sells and markets Fetal-Fibronectin ELISA (immunoassay) for assessing a pregnant woman's risk for delivering prematurely. The firm has FDA system for rapid Fetal Fibronectin testing - the TLi(tm) System - one hour turnaround test. Adeza designs, manufactures and markets innovative products for women's health. Adeza's initial focus is on reproductive healthcare, using its proprietary technologies to predict preterm birth and assess infertility. Adeza's principal product is a patented diagnostic test, Full Term, The Fetal Fibronectin Test, which utilizes a single-use, disposable cassette and is analyzed on Adeza's patented TLiIQ(R) System. This product is approved by the U.S. Food and Drug Administration (FDA) for broad use in assessing the risk of preterm birth. Adeza also markets and sells the E-tegrity(R) Test, an infertility-related test to assess receptivity of the uterus to embryo implantation in women with unexplained infertility.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Publicly Traded
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2000 2 NIH $629,611
Project Title: HLA G Immunoassay For Monitoring Placental Function
1996 1 NIH $99,948
Project Title: Antiovarian Antibody Diagnostic Test For Infertility
1996 1 NIH $99,937
Project Title: Uterine Receptivity Defects Testing Using Beta3 Integrin
1992 1 NIH $25,750
Project Title: Immunodetection of women at risk for pre-term delivery
1991 2 Army $340,141
Project Title: Diagnosis of natural and induced diseases of military importance

Key People / Management

  Emory V Anderson -- Chief Executive Officer

  David C Casal

  David E Charlton

  Mark Fischer-Colbrie -- Chief Financial Officer

  Nalini N Murdter

  Ronald Y Pong

  Simon Shorter

  Madhu Varma

Company News

There are no news available.